Stock LVTX LAVA THERAPEUTICS N.V.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus LAVA Therapeutics N.V.

Equities

LVTX

NL0015000AG6

Real-time Estimate Cboe BZX
Other stock markets
 11:53:42 2024-04-26 am EDT 		5-day change 1st Jan Change
2.79 USD +5.68% Intraday chart for LAVA Therapeutics N.V. +0.74% +72.78%
Mar. 20 LAVA Therapeutics N.V. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Mar. 20 LAVA Therapeutics N.V. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI

Evolution of the average Target Price on LAVA Therapeutics N.V.

Price target over the last 5 years

History of analyst recommendation changes

0d81.46yGwrRj5Vmz7oujkVQ71UA9tOcgSpDmup_yq1n2N2E.rJXRtewt3Rre1vH51Wds5Dhy2KV6M6DR7sjD7CiZfj675s645hKQMemn_A~189101be9a42abdf9a6531459507a706

Analyst Recommendations on LAVA Therapeutics N.V.

HC Wainwright Adjusts Price Target on Lava Therapeutics to $6 From $9, Maintains Buy Rating MT
HC Wainwright Starts Lava Therapeutics at Buy With $9 Price Target MT
SVB Securities Adjusts Price Target on Lava Therapeutics to $28 From $25, Keeps Outperform Rating MT
JMP Securities Starts Lava Therapeutics at Market Outperform With $6 Price Target MT
SVB Securities Adjusts LAVA Therapeutics' Price Target to $25 From $23, Keeps Outperform Rating MT
SVB Leerink Adjusts Price Target on Lava Therapeutics to $20 from $24, Keeps Outperform Rating MT
LAVA THERAPEUTICS B : SVB Leerink Adjusts Price Target on LAVA Therapeutics to $24 From $26, Maintains Outperform Rating MT
LAVA THERAPEUTICS B : JP Morgan Starts Lava Therapeutics at Overweight with $22 Price Target MT
LAVA THERAPEUTICS B : Jefferies Starts Lava Therapeutics at Buy with $23 Price Target MT
LAVA THERAPEUTICS B : SVB Leerink Initiates LAVA Therapeutics at Outperform Rating With $26 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
2.464 EUR
Average target price
6.684 EUR
Spread / Average Target
+171.21%
High Price Target
10.13 EUR
Spread / Highest target
+311.05%
Low Price Target
5.527 EUR
Spread / Lowest Target
+124.27%

Consensus detail

Consensus revision (last 18 months)

Analysts covering LAVA Therapeutics N.V.

HC Wainwright
SVB Securities LLC
JMP Securities
SVB Leerink
J.P. Morgan Chase
Jefferies & Co.

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. LVTX Stock
  4. Consensus LAVA Therapeutics N.V.